Iatia achieves positive quarter
Wednesday, 27 July, 2005
Microscopy company Iatia (ASX:IAT) will achieve its first positive operating cash flow quarter for the period ended June 30.
The result follows the signing of a AUD$2.97 million contract to demonstrate Iatia's imaging technology to the Defence Science and Technology Organisation and the receipt of the first instalment fee under the contract. GE Healthcare also placed its largest order to date of $140,000 in the first quarter of 2005-2006 and Iatia expects orders to increase steadily as GE continues to roll out its product.
Despite a cash balance of just $611,000 at June 30, Iatia said it expected future income and lines of financial equity support to be more than adequate to meet its cash flow and working capital requirements for the next 12 months.
The University of Sydney formalises cervical cancer elimination partnership
The success of a cervical cancer elimination program has led to the signing of a memorandum of...
Noxopharm says paper reveals science behind its immune system platform
Clinical-stage Australian biotech company Noxopharm Limited says a Nature Immunology...
Neurosensing/neurostimulation implants session to be held on Monday
On Monday, a session at UNSW Sydney will include people who are benefiting from bioelectronics...
